Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats

J Neuroendocrinol. 2000 Oct;12(10):1022-6. doi: 10.1046/j.1365-2826.2000.00563.x.

Abstract

The effects of conditioned fear on the release of noradrenaline in the hypothalamic paraventricular nucleus (PVN) and the involvement of corticotropin-releasing factor (CRF) receptor type 1 (CRFR1) in conditioned fear-induced changes in noradrenaline release were examined by intracerebral microdialysis in rats. Conditioned fear was produced by placing animals into a box where they had previously been exposed to a 5-min period of electric footshock, 135 min prior to the start of experiment. Conditioned fear for 20 min produced a significant increase in the release of noradrenaline in the PVN. Intraperitoneal preadministration of a selective nonpeptidic CRFR1 antagonist, CRA1000, completely blocked the conditioned fear-induced release of noradrenaline. These results suggest that CRFR1 is involved in the release of noradrenaline in the hypothalamic PVN induced by conditioned fear.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Conditioning, Psychological / drug effects
  • Conditioning, Psychological / physiology*
  • Electroshock
  • Fear / drug effects
  • Fear / physiology*
  • Hindlimb
  • Male
  • Microdialysis
  • Norepinephrine / antagonists & inhibitors*
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism*
  • Pyridines / pharmacology*
  • Pyrimidines / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Corticotropin-Releasing Hormone / antagonists & inhibitors*

Substances

  • Pyridines
  • Pyrimidines
  • Receptors, Corticotropin-Releasing Hormone
  • CRA1000
  • CRF receptor type 1
  • Norepinephrine